Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 75

Results For "MEA"

1303 News Found

Imfinzi plus Imjudo recommended for approval in the EU by CHMP for advanced liver and lung cancers
Drug Approval | December 20, 2022

Imfinzi plus Imjudo recommended for approval in the EU by CHMP for advanced liver and lung cancers

Positive opinions based on significant survival benefit


Biocon initiates clinical study of Itolizumab for ulcerative colitis in India
Clinical Trials | December 15, 2022

Biocon initiates clinical study of Itolizumab for ulcerative colitis in India

This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study


Moderna and Merck announce personalized mRNA cancer vaccine
Clinical Trials | December 13, 2022

Moderna and Merck announce personalized mRNA cancer vaccine

Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial


GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
Clinical Trials | December 12, 2022

GSK’s new data underscore important responses with momelotinib for myelofibrosis patients

48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response


Emmes launches Cell and Gene Therapy Center
News | December 09, 2022

Emmes launches Cell and Gene Therapy Center

The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies


BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria
Healthcare | December 09, 2022

BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria

35 million mosquito nets supplied to countries in sub-Saharan Africa through partners


Atlas Copco acquires Shandong Meditech Medical Technology
News | December 07, 2022

Atlas Copco acquires Shandong Meditech Medical Technology

Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.


Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations
News | December 07, 2022

Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations

GMP-compliant documentation of all manufacturing steps for cell and gene therapies